OTLK Outlook Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 18, 2026
$0.59
· of 52w range
· above low
· to high
$0.1652w low
$2.5452w high
Market Cap (MRQ)
$111M
P/E
-0.3
EPS
$-1.79
Revenue
$1M
your badges
52W Range
$0–$3
Analyst Rating
BUY
Price Target
$5
P/E
-0.3
ROE
193.1%
Net Profit Margin
-4416.2%
Your badge strip is empty — pin a metric anywhere on this page.
OTLK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.59
Market Cap (MRQ)
$111M
P/E
-0.3
EPS
$-1.79
Revenue
$1M
ROE
193.1%
52W Range
$0–$3
OTLK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| March 14, 2024 | 1-for-20 | Reverse |
| March 18, 2019 | 1-for-8 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1M2018-09-30 → 2025-09-30
EPS$-1.792020-09-30 → 2025-09-30
Free Cash Flow·2019-09-30 → 2019-09-30
Net margin-4416.2%2019-09-30 → 2025-09-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | OTLK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.35Y avg ≈-41.1 | ≈-41.1 | · | · | |
| P/S | 22.6 | · | 60.9 | Undervalued | |
| P/B (MRQ) | -10.7 | · | · | · | |
| Price / Cash Flow | -0.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | OTLK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 4.0% | · | · | · | |
| Operating Margin | -4744.2% | · | -3077.6% | Weak | |
| EBITDA Margin | -4744.2% | · | -3077.6% | Weak | |
| Pretax Margin | -4526.0% | · | -3650.4% | Weak | |
| Net Profit Margin | -4416.2% | · | -3650.4% | Weak | |
| ROA | -263.4% | · | -67.9% | Weak | |
| ROE | 193.1% | · | -113.9% | Top tier | |
| ROIC | 203.3% | · | -75.7% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | OTLK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.8 | · | 4.5 | Low liquidity | |
| Quick Ratio | 0.2 | · | 2.4 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | OTLK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | Top tier | |
| Inventory Turnover | 0.8 | · | · | · | |
| Receivables Turnover | 1.9 | · | · | · | |
| Revenue / Employee | ≈$83.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-4.0%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2026 | $-0.09 | $-0.10 | 5.5% | |
| June 30, 2026 | Aug 14, 2026 | $-0.09 | $-0.09 | -1.8% |
| March 31, 2026 | May 15, 2026 | $-0.16 | $-0.12 | -30.7% |
| Dec. 31, 2025 | $-0.22 | $-0.18 | -24.4% | |
| Sept. 30, 2025 | $-0.19 | $-0.26 | 26.5% | |
| June 30, 2025 | $-0.55 | $-0.40 | -37.1% | |
| March 31, 2025 | $-0.40 | $-0.61 | 34.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | · | · | · | · | · | $8M | $3M | |
| Cost of Revenue | $1M | · | · | · | · | · | · | · | |
| Gross Profit | $57.2K | · | · | · | · | · | · | · | |
| R&D Expense | $27M | $42M | $26M | $42M | $39M | $26M | $24M | $19M | |
| SG&A Expense | $40M | $30M | $27M | $21M | $13M | $10M | $9M | $14M | |
| Operating Expenses | · | · | · | · | $52M | $37M | $44M | $33M | |
| Operating Income | $-67M | $-72M | $-53M | $-63M | $-52M | $-37M | $-36M | $-30M | |
| Interest Expense | · | · | · | · | · | $2M | $3M | $4M | |
| Interest Income | $89.7K | $906.1K | $971.5K | · | · | · | · | · | |
| Pretax Income | $-64M | $-75M | $-59M | $-66M | $-53M | $-39M | $-38M | $-34M | |
| Income Tax | $-2M | $2.8K | $2.8K | $2.8K | $2.0K | $-3M | $-3M | $-4M | |
| Net Income | $-62M | $-75M | $-59M | $-66M | $-53M | $-35M | $-35M | $-30M | |
| EPS (Basic) | $-1.79 | $-4.06 | $-4.72 | $-0.31 | $-0.35 | $-0.67 | · | · | |
| EPS (Diluted) | $-1.79 | $-4.06 | $-4.72 | $-0.31 | $-0.35 | $-0.67 | · | · | |
| Shares (Basic) | 34,796,120 | 18,548,813 | 12,508,817 | 212,079,472 | 152,676,145 | 72,555,636 | · | · | |
| Shares (Diluted) | 34,796,120 | 18,548,813 | 12,508,817 | 212,079,472 | 152,676,145 | 72,555,636 | · | · | |
| EBITDA | $-67M | · | · | · | $-52M | · | $-33M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $15M | $23M | $17M | $14M | $13M | $8M | $2M | |
| Receivables | $1M | · | · | · | · | · | · | · | |
| Inventory | $3M | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $12M | $8M | $10M | $7M | $5M | $5M | $2M | |
| Current Assets | $17M | $27M | $31M | $28M | $22M | $18M | $14M | $3M | |
| PP&E (Net) | · | · | · | · | $163.6K | $327.2K | $3M | $18M | |
| PP&E (Gross) | · | · | · | $1M | $1M | $1M | $4M | $30M | |
| Accum. Depreciation | · | · | · | $1M | $903.7K | $740.1K | $1M | $12M | |
| Other Non-current Assets | $417.5K | $439.3K | $501.3K | $132.0K | $174.6K | $1M | $457.5K | $491.0K | |
| Total Assets | $19M | $29M | $32M | $29M | $23M | $20M | $17M | $22M | |
| Accounts Payable | $10M | $8M | $7M | $3M | $2M | $2M | $2M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $3M | $2M | $8M | $5M | $6M | |
| Current Liabilities | $46M | $43M | $47M | $20M | $7M | $16M | $20M | $32M | |
| Capital Leases | $188.8K | $246.9K | · | · | $27.0K | · | $3M | $3M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $4M | $4M | |
| Total Liabilities | $51M | $102M | $47M | $20M | $18M | $17M | $28M | $43M | |
| Long-term Debt | · | · | · | · | · | · | $1.08B | $165.0K | |
| Total Debt | · | · | · | · | · | · | $1M | · | |
| Common Stock | $538.9K | $239.1K | $130.1K | $2M | $2M | $1M | $286.1K | $90.3K | |
| Retained Earnings | $-606M | $-543M | $-468M | $-409M | $-343M | $-290M | $-254M | $-216M | |
| Stockholders' Equity | $-32M | $-73M | $-14M | $9M | $5M | $3M | $-16M | $-26M | |
| Liabilities + Equity | $19M | $29M | $32M | $29M | $23M | $20M | $17M | $22M | |
| Shares Outstanding | 53,887,233 | 23,905,635 | 13,012,833 | 227,310,572 | 176,461,628 | 127,183,109 | 28,609,995 | 9,027,491 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $117.1K | $113.9K | $44.2K | $204.7K | $262.1K | $219.4K | $3M | $3M | |
| Stock-based Comp | $9M | $5M | $6M | $8M | $5M | $3M | $1M | $2M | |
| Other Non-cash | · | · | · | · | · | · | $-2M | · | |
| Operating Cash Flow | $-52M | $-69M | $-43M | $-57M | $-54M | $-32M | $-32M | $-33M | |
| CapEx | · | · | · | · | · | · | $437.3K | $3M | |
| Investing Cash Flow | · | · | · | · | · | $-900.0K | $-437.3K | $-3M | |
| Stock Issued | $25M | $60M | $30M | $62M | $46M | $35M | $46M | $15M | |
| Net Stock Activity | $25M | · | · | · | $46M | · | $46M | · | |
| Financing Cash Flow | $45M | $60M | $49M | $60M | $56M | $37M | $39M | $34M | |
| Net Change in Cash | $-7M | $-8M | $6M | $3M | $2M | $5M | $6M | $-1M | |
| Free Cash Flow | · | · | · | · | · | · | $-33M | · | |
| Levered FCF | · | · | · | · | · | · | $-36M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.0% | · | · | · | · | · | · | · | |
| Operating Margin | -4744.2% | · | · | · | 5525.6% | · | -445.6% | · | |
| Net Margin | -4416.2% | · | · | · | 5679.1% | · | -423.8% | · | |
| Pretax Margin | -4526.0% | · | · | · | 5678.9% | · | -465.7% | · | |
| EBITDA Margin | -4744.2% | · | · | · | 5525.6% | · | -404.3% | · | |
| ROA | -263.4% | · | · | · | -249.9% | · | -175.2% | · | |
| ROE | 193.1% | · | · | · | -612.6% | · | 165.7% | · | |
| ROIC | 203.3% | · | · | · | -1122.7% | · | 219.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | · | · | · | 3.2 | · | 0.7 | · | |
| Quick Ratio | 0.2 | · | · | · | 2.1 | · | 0.4 | · | |
| Debt / Equity | · | · | · | · | · | · | -0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | -0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | -10.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | · | -0.0 | · | 0.4 | · | |
| Inventory Turnover | 0.8 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.9 | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.60 | · | · | · | $0.03 | · | $-0.56 | · | |
| Revenue / Share | $0.04 | · | · | · | $-0.01 | · | · | · | |
| Cash Flow / Share | $-1.49 | · | · | · | $-0.36 | · | · | · | |
| Cash / Share | $0.15 | · | · | · | $0.08 | · | $0.28 | · | |
| EPS (TTM) | $-1.79 | $-4.06 | $-4.72 | $-0.31 | $-0.35 | $-0.67 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | · | · | · | · | · | $8M | $3M | |
| Net Income TTM | $-62M | $-75M | $-59M | $-66M | $-53M | $-35M | $-35M | $-30M | |
| Market Cap | $57M | · | · | · | $7.66B | · | $853M | · | |
| Enterprise Value | · | · | · | · | · | · | $846M | · | |
| P/E | -0.6 | -1.3 | -0.9 | -78.7 | -124.0 | -21.5 | · | · | |
| P/S | 40.4 | · | · | · | · | · | 104.7 | · | |
| P/B | -1.8 | · | · | · | 1662.2 | · | -52.9 | · | |
| P / Tangible Book | · | · | · | 634.8 | 1662.2 | 648.0 | · | · | |
| P / Cash Flow | -1.1 | · | · | · | -141.2 | · | -26.4 | · | |
| P / FCF | · | · | · | · | · | · | -26.1 | · | |
| EV / EBITDA | · | · | · | · | · | · | -25.7 | · | |
| EV / FCF | · | · | · | · | · | · | -25.8 | · | |
| EV / Revenue | · | · | · | · | · | · | 103.8 | · | |
| Earnings Yield | -168.9% | -76.0% | -106.8% | -1.3% | -0.81% | -4.7% | · | · |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $-91.8K | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $17.0K | $149.3K | $29.6K | $916.5K | $439.8K | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $-8.3K | $-21.9K | $-1M | $-1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $3M | $5M | $4M | $6M | $7M | $4M | $10M | $13M | $11M | $14M | $5M | $5M | $11M | $544.9K | $10M | $9M | |
| SG&A Expense | $8M | $10M | $9M | $10M | $10M | $8M | $12M | $10M | $8M | $5M | $6M | $8M | $7M | $6M | $6M | $5M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $20M | $19M | · | · | $18M | $7M | · | · | |
| Operating Income | $-11M | $-14M | $-13M | $-17M | $-16M | $-12M | $-22M | $-23M | $-20M | $-19M | $-10M | $-12M | $-18M | $-7M | $-16M | $-14M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | $303 | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | $240.0K | $404.6K | · | · | $306.0K | $395.5K | · | · | · | |
| Pretax Income | $-20M | $-4M | · | $-15M | $-20M | $-46M | · | $6M | $44M | $-114M | · | $-13M | $-21M | $-7M | · | $-14M | |
| Income Tax | · | · | · | $-2M | $0 | $2.8K | · | $0 | $0 | $2.8K | · | $0 | $0 | $2.8K | · | $800 | |
| Net Income | $-20M | $-4M | $-23M | $-13M | $-20M | $-46M | $17M | $6M | $44M | $-114M | $-11M | $-13M | $-21M | $-7M | $-19M | $-14M | |
| EPS (Basic) | $-0.15 | $-0.05 | $-0.38 | $-0.46 | $-0.55 | $-1.50 | $0.72 | $2.90 | $1.91 | $-8.01 | $-0.86 | $-2.51 | $-1.61 | $-0.52 | $-0.08 | $-0.06 | |
| EPS (Diluted) | $-0.15 | $-0.05 | $-0.38 | $-0.46 | $-0.55 | $-1.50 | $0.72 | $5.70 | $-0.89 | $-8.01 | $-0.86 | $-2.51 | $-1.61 | $-0.52 | $-0.08 | $-0.06 | |
| Shares (Basic) | 136,743,333 | 81,835,900 | 60,205,035 | · | 36,956,582 | 30,874,396 | 24,233,957 | · | 23,227,069 | 14,270,289 | 13,012,833 | · | 12,844,079 | 12,833,330 | 227,410,533 | · | |
| Shares (Diluted) | 136,743,333 | 81,835,900 | 60,205,035 | · | 36,956,582 | 30,874,396 | 24,233,957 | · | 25,476,438 | 14,270,289 | 13,012,833 | · | 12,844,079 | 12,833,330 | 227,410,533 | · | |
| EBITDA | $-11M | $-14M | $-13M | · | $-16M | $-12M | $-22M | · | $-20M | $-19M | $-10M | · | $-18M | $-7M | $-16M | · |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $8M | $9M | $8M | $9M | $8M | $6M | $15M | $32M | $47M | $10M | $23M | $34M | $44M | $52M | $17M | |
| Receivables | $2M | $3M | $114.6K | $1M | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $5M | $3M | $3M | $3M | $4M | $4M | $3M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $7M | $5M | $4M | $6M | $7M | $7M | $12M | $14M | $11M | $10M | $8M | $9M | $9M | $9M | $10M | |
| Current Assets | $23M | $21M | $17M | $17M | $21M | $18M | $16M | $27M | $46M | $58M | $20M | $31M | $43M | $53M | $62M | $28M | |
| Other Non-current Assets | $304.0K | $320.3K | $346.1K | $417.5K | $464.4K | $393.8K | $416.0K | $439.3K | $479.2K | $473.2K | $484.3K | $501.3K | $589.4K | $113.8K | $126.4K | $132.0K | |
| Total Assets | $26M | $22M | $18M | $19M | $22M | $19M | $17M | $29M | $47M | $59M | $22M | $32M | $44M | $54M | $63M | $29M | |
| Accounts Payable | $7M | $14M | $7M | $10M | $10M | $8M | $12M | $8M | $6M | $4M | $3M | $7M | $5M | $4M | $4M | $3M | |
| Accrued Liabilities | $3M | $9M | $5M | $5M | $5M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $8M | $6M | $9M | $3M | |
| Current Liabilities | $29M | $39M | $49M | $46M | $31M | $25M | $48M | $43M | $43M | $54M | $46M | $47M | $50M | $44M | $15M | $20M | |
| Capital Leases | $140.1K | $157.0K | $172.0K | $188.8K | $204.1K | $219.0K | $233.1K | $246.9K | $260.4K | · | · | · | · | · | · | · | |
| Total Liabilities | $37M | $51M | $57M | $51M | $60M | $52M | $67M | $102M | $131M | $193M | $46M | $47M | $50M | $44M | $47M | $20M | |
| Common Stock | $2M | $1M | $645.6K | $538.9K | $434.8K | $329.1K | $249.1K | $239.1K | $234.1K | $220.1K | $3M | $130.1K | $3M | $3M | $3M | $2M | |
| Retained Earnings | $-654M | $-633M | $-629M | $-606M | $-592M | $-572M | $-526M | $-543M | $-549M | $-593M | $-479M | $-468M | $-455M | $-434M | $-428M | $-409M | |
| Stockholders' Equity | $-10M | $-29M | $-39M | $-32M | $-37M | $-32M | $-50M | $-73M | $-84M | $-134M | $-24M | $-14M | $-6M | $10M | $16M | $9M | |
| Liabilities + Equity | $26M | $22M | $18M | $19M | $22M | $19M | $17M | $29M | $47M | $59M | $22M | $32M | $44M | $54M | $63M | $29M | |
| Shares Outstanding | 187,096,998 | 104,614,219 | 64,556,570 | 53,887,233 | 43,479,051 | 32,907,014 | 24,905,635 | 23,905,635 | 23,405,637 | 22,012,827 | 260,257,517 | 13,012,833 | 258,704,055 | 256,666,794 | 256,666,794 | 227,310,572 |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13.8K | $30.4K | $30.1K | $29.7K | $29.4K | $29.1K | $28.8K | $28.8K | $28.7K | $28.2K | $28.2K | $11.2K | $11.2K | $11.0K | $10.8K | $51.5K | |
| Stock-based Comp | $791.7K | $757.5K | $881.1K | $2M | $2M | $2M | $4M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-21M | $-8M | $-15M | $-12M | $-12M | $-17M | $-11M | $-17M | $-20M | $-19M | $-13M | $-13M | $-13M | $-8M | $-9M | $-10M | |
| Stock Issued | $25M | $7M | $15M | $8M | $14M | $1M | $2M | $-115.0K | $4M | · | · | $2M | $3M | $-339.3K | $25M | $2M | |
| Net Stock Activity | · | · | $15M | · | · | · | $2M | · | · | · | · | · | · | · | $25M | · | |
| Financing Cash Flow | $27M | $7M | $16M | $12M | $13M | $18M | $2M | $-115.0K | $4M | $56M | $-3.2K | $2M | $3M | $-597.1K | $44M | $2M | |
| Net Change in Cash | $3M | $-929.2K | $594.3K | $-817.7K | $1M | $2M | $-9M | $-17M | $-15M | $37M | $-13M | $-10M | $-10M | $-9M | $35M | $-9M |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -118071.4% | -729600.0% | · | · | 70.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -154431557.1% | -467566233.3% | · | · | -1046.2% | 66974.0% | -44203.0% | · | · | 614.1% | -5471.3% | · | -4590.0% | -3641.2% | 640.7% | · | |
| Net Margin | -290275314.3% | -148436033.3% | · | · | -1338.8% | 250552.4% | 35550.9% | · | · | 3705.8% | -5924.5% | · | -5231.1% | -3543.4% | 762.2% | · | |
| Pretax Margin | -290275314.3% | -148436033.3% | · | · | -1338.8% | 250537.3% | · | · | · | 3705.7% | · | · | -5231.1% | -3541.9% | · | · | |
| EBITDA Margin | -154431557.1% | -467566233.3% | · | · | -1046.2% | 66974.0% | -44203.0% | · | · | 614.1% | -5471.3% | · | -4590.0% | -3641.2% | 640.7% | · | |
| ROA | -83.7% | -21.7% | -130.8% | · | -58.0% | -118.7% | 89.8% | · | 97.0% | -202.2% | -26.5% | · | -49.8% | -10.9% | -26.4% | · | |
| ROE | 85.4% | 14.5% | 51.9% | · | 33.4% | 55.6% | -46.6% | · | -99.6% | 184.7% | 260.4% | · | -283.6% | -28.6% | -57.8% | · | |
| ROIC | · | · | · | · | · | 38.2% | · | · | · | 14.1% | · | · | · | -65.2% | · | · |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.5 | 0.3 | · | 0.7 | 0.7 | 0.3 | · | 1.1 | 1.1 | 0.4 | · | 0.9 | 1.2 | 4.1 | · | |
| Quick Ratio | 0.4 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.8 | 0.9 | 0.2 | · | 0.7 | 1.0 | 3.5 | · |
Efficiency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.0 | 0.0 | · | · | -0.1 | 0.0 | · | 0.0 | 0.0 | -0.0 | · | |
| Inventory Turnover | 0.0 | 0.0 | 0.0 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | 0.0 | 0.0 | · | 1.7 | · | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.06 | $-0.28 | $-0.60 | · | $-0.86 | $-0.99 | $-2.02 | · | $-3.57 | $-6.10 | $-0.09 | · | $-0.02 | $0.04 | $0.06 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | · | $0.04 | $-0.00 | $0.00 | · | · | $-0.22 | $0.00 | · | $0.00 | $0.00 | $-0.01 | · | |
| Cash Flow / Share | · | · | $-0.25 | · | · | · | $-0.45 | · | · | · | $-0.05 | · | · | · | $-0.04 | · | |
| Cash / Share | $0.06 | $0.07 | $0.13 | · | $0.20 | $0.23 | $0.23 | · | $1.37 | $2.15 | $0.04 | · | $0.13 | $0.17 | $0.20 | · | |
| EPS (TTM) | $-1.04 | $-1.44 | $-2.89 | · | $4.37 | $4.03 | $-2.48 | · | $-12.27 | $-12.99 | $-5.50 | · | $-2.27 | $-0.74 | $-0.31 | · |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $8M | $8M | · | $8M | $8M | $8M | · | $8M | $8M | $8M | · | |
| Net Income TTM | $-61M | $-61M | $-103M | · | $-43M | $21M | $-47M | · | $-94M | $-159M | $-51M | · | $-60M | $-57M | $-70M | · | |
| Market Cap | $297M | $22M | $102M | · | $70M | $40M | $47M | · | $173M | $263M | $2.05B | · | $9.00B | $5.60B | $5.54B | · | |
| P/E | -1.5 | -0.1 | -0.5 | · | 0.4 | 0.3 | -0.8 | · | -0.6 | -0.9 | -1.4 | · | -15.3 | -29.5 | -69.7 | · | |
| P/S | · | · | · | · | · | 4.9 | 5.8 | · | 21.2 | 32.3 | 251.8 | · | 1105.2 | 686.9 | 680.6 | · | |
| P/B | -28.6 | -0.7 | -2.6 | · | -1.9 | -1.2 | -0.9 | · | -2.1 | -2.0 | -84.2 | · | -1636.0 | 533.5 | 351.8 | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | 533.5 | 351.8 | · | |
| P / Cash Flow | · | · | -6.8 | · | · | · | -4.3 | · | · | · | -157.4 | · | · | · | -622.8 | · | |
| Earnings Yield | -65.4% | -699.0% | -182.9% | · | 273.1% | 330.3% | -131.2% | · | -166.3% | -108.8% | -69.8% | · | -6.5% | -3.4% | -1.4% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Revenue | $1M | · | · | · | · |
| Gross Margin % | 4.0% | · | · | · | · |
| Operating Margin % | -4744.2% | · | · | · | 5525.6% |
| Net Income | $-62M | $-75M | $-59M | $-66M | $-53M |
| Diluted EPS | $-1.79 | $-4.06 | $-4.72 | $-0.31 | $-0.35 |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Current Ratio | 0.4 | · | · | · | 3.2 |
| Quick Ratio | 0.2 | · | · | · | 2.1 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 77 filers · $35.5M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
77
Value held
$35.5M
New positions
28
Exited positions
13
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (+11 vs prior Q) | 13 (-3 vs prior Q) | 25 (+9 vs prior Q) | 8 (-2 vs prior Q) | +10.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $6,959,226 | 4,376,872 | 19.61% | Shares |
| PERCEPTIVE ADVISORS LLC | $4,991,353 | 3,139,216 | 14.06% | Shares |
| MARSHALL WACE, LLP | $3,160,248 | 1,987,578 | 8.90% | Shares |
| BlackRock, Inc. | $2,653,040 | 1,668,579 | 7.48% | Shares |
| VANGUARD GROUP INC | $2,314,964 | 1,465,167 | 6.52% | Shares |
| JANE STREET GROUP, LLC | $2,266,179 | 1,425,270 | 6.39% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,981,050 | 1,245,868 | 5.58% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,539,422 | 968,190 | 4.34% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,052,046 | 661,664 | 2.96% | Shares |
| GILPIN WEALTH MANAGEMENT, LLC | $882,450 | 555,000 | 2.49% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $862,098 | 542,200 | 2.43% | Call option |
| STATE STREET CORP | $858,285 | 539,802 | 2.42% | Shares |
| Sanctuary Advisors, LLC | $547,801 | 344,529 | 1.54% | Shares |
| RAYMOND JAMES FINANCIAL INC | $527,961 | 332,051 | 1.49% | Shares |
| GROUP ONE TRADING LLC | $391,821 | 246,428 | 1.10% | Shares |
| NORTHERN TRUST CORP | $377,722 | 237,561 | 1.06% | Shares |
| CITADEL ADVISORS LLC | $360,294 | 226,600 | 1.02% | Put option |
| CANTOR FITZGERALD, L. P. | $357,750 | 225,000 | 1.01% | Shares |
| SIMPLEX TRADING, LLC | $325,970 | 205,013 | 0.92% | Shares |
| LPL Financial LLC | $294,058 | 184,942 | 0.83% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $284,928 | 179,200 | 0.80% | Put option |
| JANE STREET GROUP, LLC | $277,137 | 174,300 | 0.78% | Call option |
| CITADEL ADVISORS LLC | $265,689 | 167,100 | 0.75% | Call option |
| UBS Group AG | $242,022 | 152,215 | 0.68% | Shares |
| DEUTSCHE BANK AG\ | $207,813 | 130,700 | 0.59% | Shares |
| Wealth Management Partners, LLC | $187,890 | 118,170 | 0.53% | Shares |
| GILPIN WEALTH MANAGEMENT, LLC | $159,000 | 100,000 | 0.45% | Call option |
| Jefferies Financial Group Inc. | $99,375 | 62,500 | 0.28% | Shares |
| MILLENNIUM MANAGEMENT LLC | $91,964 | 57,839 | 0.26% | Shares |
| JANE STREET GROUP, LLC | $91,902 | 57,800 | 0.26% | Put option |
| Tower Research Capital LLC (TRC) | $91,252 | 57,391 | 0.26% | Shares |
| Royal Fund Management, LLC | $75,048 | 47,200 | 0.21% | Shares |
| SCOTIA CAPITAL INC. | $73,617 | 46,300 | 0.21% | Shares |
| Vanguard Global Advisers, LLC | $65,408 | 41,137 | 0.18% | Shares |
| Belvedere Trading LLC | $65,029 | 40,899 | 0.18% | Shares |
| Steward Partners Investment Advisory, LLC | $46,905 | 29,500 | 0.13% | Shares |
| Christensen, King & Associates Investment Services, Inc. | $45,040 | 28,327 | 0.13% | Shares |
| PNC Financial Services Group, Inc. | $39,750 | 25,000 | 0.11% | Shares |
| Vanguard Personalized Indexing Management, LLC | $38,349 | 24,119 | 0.11% | Shares |
| Flower City Capital | $31,800 | 20,000 | 0.09% | Shares |
| Bank of New York Mellon Corp | $29,676 | 18,664 | 0.08% | Shares |
| Signet Private Wealth LLC | $27,912 | 17,555 | 0.08% | Shares |
| MORGAN STANLEY | $26,960 | 16,956 | 0.08% | Shares |
| NewEdge Advisors, LLC | $26,588 | 16,722 | 0.07% | Shares |
| TWO SIGMA SECURITIES, LLC | $23,619 | 14,855 | 0.07% | Shares |
| OPPENHEIMER & CO INC | $22,260 | 14,000 | 0.06% | Shares |
| HARBOUR INVESTMENTS, INC. | $19,563 | 12,304 | 0.06% | Shares |
| OSAIC HOLDINGS, INC. | $18,228 | 11,466 | 0.05% | Shares |
| Simplicity Wealth,LLC | $17,983 | 11,310 | 0.05% | Shares |
| Fifth Third Wealth Advisors LLC | $15,900 | 10,000 | 0.04% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| GMS Ventures & Investments, SUKHTIAN GHIATH M. ×5 filings | Aug. 14, 2026 | 16.40% | Amendment | · | SEC |
| Syntone Ventures LLC, Syntone LLC, Syntone Technologies Group Co., Ltd. ×3 filings | April 17, 2024 | · | Initial filing | · | SEC |
| GMS Ventures and Investments, Ghiath M. Sukhtian ×3 filings | March 20, 2024 | · | Initial filing | · | SEC |
| Tenshi Healthcare Pte. Ltd., Arun Kumar Pillai ×3 filings | Jan. 31, 2024 | · | Initial filing | · | SEC |
| BioLexis Pte. Ltd., Arun Kumar Pillai, Ghiath M. Sukhtian, GMS Ventures and Investments ×13 filings | April 22, 2022 | · | Initial filing | · | SEC |
| GMS Tenshi Holdings Pte. Limited, Ghiath M. Sukhtian, Arun Kumar Pillai ×4 filings | July 20, 2018 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 31 insiders · 10 officers · 20 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Russell C Trenary III | CEO AND PRESIDENT | March 20, 2024 A | 54,925 | 0 | 0 | $0 |
| Kevin Michael Lundquist | Chief Financial Officer | Sept. 1, 2026 A | · | 0 | 0 | $0 |
| Lawrence A Kenyon | Chief Financial Officer | Aug. 14, 2026 P | 106,956 | 0 | 0 | $0 |
| Jeff Evanson | CHIEF COMMERCIAL OFFICER | March 20, 2024 A | 808,459 | 0 | 0 | $0 |
| Terry Dagnon | Chief Operations Officer | April 20, 2023 S | 653,058 | 0 | 0 | $0 |
| Kenneth Bahrt | Chief Medical Officer | Feb. 19, 2019 A | 47,120 | 0 | 0 | $0 |
| Stephen J Mcandrew | SVP Bus. Strat. & Dev. | Oct. 22, 2018 A | 50,899 | 0 | 0 | $0 |
| Elizabeth A. Yamashita | VP, Regulatory Affairs | Dec. 22, 2017 S | 64,648 | 0 | 0 | $0 |
| Kogan Bao | VP, Analytical Sciences | Dec. 21, 2016 A | 71,739 | 0 | 0 | $0 |
| Scott A. Gangloff | SVP, Development & Mfrg | Dec. 21, 2016 A | 118,573 | 0 | 0 | $0 |
| Faisal Ghiath Sukhtian | Director | July 29, 2026 P | 220,972 | 2 | 0 | $150,259 |
| Yezan Munther Haddadin | Director | June 2, 2026 P | 66,167 | 2 | 0 | $39,030 |
| Randy H Thurman | Director | May 26, 2026 P | 5,593 | 1 | 0 | $2,150 |
| Kurt J Hilzinger | Director | May 26, 2026 P | 423,655 | 1 | 0 | $176,000 |
| Andong Huang | Director | Oct. 3, 2025 A | · | 0 | 0 | $0 |
| Julia A Haller | Director | Oct. 3, 2025 A | · | 0 | 0 | $0 |
| Gerd Auffarth | Director | Oct. 3, 2025 A | · | 0 | 0 | $0 |
| Julian S Gangolli | Director | Oct. 1, 2025 A | · | 0 | 0 | $0 |
| Arun Kumar Pillai | Director | Feb. 1, 2022 J | 22,982,529 | 0 | 0 | $0 |
| Joe Thomas | Director | Oct. 3, 2019 A | · | 0 | 0 | $0 |
| Pankaj Mohan | Director | Jan. 15, 2019 P | 7,064,553 | 0 | 0 | $0 |
| Joerg Windisch | Director | Nov. 9, 2018 A | · | 0 | 0 | $0 |
| Claudio Albrecht | Director | Oct. 31, 2017 A | · | 0 | 0 | $0 |
| Albert D. Dyrness | Director | Oct. 26, 2017 A | · | 0 | 0 | $0 |
| Todd C Brady | Director | Oct. 26, 2017 A | 153,288 | 0 | 0 | $0 |
| Scott A Canute | Director | Oct. 26, 2017 A | 246,342 | 0 | 0 | $0 |
| Hoke Robin Smith | Director | Nov. 28, 2016 J | 1,939 | 0 | 0 | $0 |
| Donald J. Griffith | Director | Nov. 23, 2016 S | 144,926 | 0 | 0 | $0 |
| Syntone Ventures LLC | 10% owner | April 15, 2024 P | 1,705,438 | 0 | 0 | $0 |
| GMS Tenshi Holdings Pte. Ltd | 10% owner | April 21, 2022 J | 22,982,529 | 0 | 0 | $0 |
| Robert Charles Jahr | · | Aug. 14, 2026 P | 151,515 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
OTLK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$4.00
+574.5%
2 20.0%
Strong Buy
5 50.0%
Buy
3 30.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-10-02Mean target $5.03 +747.4%
← Below all targets
Current price $0.59
Low$1.60
Mean$5.03
High$10.50
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 18, 2026